ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Mobius Theraputics™ 

743 Spirit 40 Park Drive
Suite 111
Chesterfield  Missouri  63005  U.S.A.
Phone: 636-519-4860 Fax: 636-519-4859


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Mobius Theraputics™ Receives Key Mitosol® Approval For 2014 1/13/2014 9:38:50 AM    More...
Mobius Theraputics™ Announces Ophthalmic Mutual Insurance Company Has Revised Consent Forms Related To Glaucoma Filtering Surgery 12/5/2013 9:55:36 AM    More...
Mobius Theraputics™ Receives Payment Indicator for Reimbursement of Mitosol® 3/11/2013 9:44:06 AM    More...
Mobius Theraputics™ Provides Update on Recall of Two Lots of Mitosol® 2/20/2013 8:13:08 AM    More...
Mobius Theraputics™ Issues a Voluntary Recall of Mitosol® 1/10/2013 7:41:26 AM    More...
Mobius Theraputics™ Announces Assignment of HCPCS Code for Mitosol® 11/8/2012 9:28:56 AM    More...
Mobius Theraputics™ Commences First Shipments of New Glaucoma Drug 7/9/2012 9:00:49 AM    More...
ICU Medical, Inc. (ICUI)'s ChemoClave(TM) System Included in Mobius Theraputics™' Mitosol(R) Kit for Use in Glaucoma Surgery 6/8/2012 10:22:44 AM    More...
Mobius Theraputics™ Receives Final FDA Approval for New Glaucoma Drug 2/10/2012 6:24:31 AM    More...
Mobius Theraputics™ Receives Investment From BioGenerator 2/4/2011 8:28:55 AM    More...
12